Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:approvalYear |
2018
|
| gptkbp:approvedBy |
gptkb:FDA
treatment of smallpox |
| gptkbp:ATCCode |
J05AX25
|
| gptkbp:CASNumber |
869572-92-9
|
| gptkbp:chemicalFormula |
C19H15F3N2O3
|
| gptkbp:developedBy |
gptkb:SIGA_Technologies
|
| gptkbp:form |
capsule
solution for injection |
| gptkbp:genericName |
gptkb:tecovirimat
|
| https://www.w3.org/2000/01/rdf-schema#label |
TPOXX
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:mechanismOfAction |
inhibits the VP37 envelope wrapping protein
|
| gptkbp:pregnancyCategory |
Not assigned (US)
|
| gptkbp:prescriptionRequired |
yes
|
| gptkbp:PubChem_CID |
25154825
DB12020 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting abdominal pain headache |
| gptkbp:storage |
room temperature
|
| gptkbp:UNII |
6L6X5W1182
|
| gptkbp:usedFor |
gptkb:monkeypox_(off-label)
orthopoxvirus infections |
| gptkbp:bfsParent |
gptkb:Siga_Technologies
|
| gptkbp:bfsLayer |
6
|